Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-17

Clinical Trial Update: Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating radiation therapy with capecitabine, with or without oxaliplatin, in patients undergoing surgery for stage II/III rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • OXALIPLATIN (Oxaliplatin)
  • Radiation therapy

Snippet

Sponsor: UNICANCER | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED